Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

Trends in the severity of opioid use disorder during pregnancy over time

Abstract

Objective

Characterize severity of opioid use disorder during pregnancy over time.

Study design

A retrospective chart review of pregnant women presenting to MetroHealth’s Mother and Child Dependency program from 2002–2019 was performed. Severity of opioid use disorder was assessed by multinomial multivariable logistic regression of five discrete measures. Term birth rates and MAT use were analyzed using univariate regression.

Results

606 women were included in this study. Duration of use, age at first use, polysubstance use, and route of administration did not significantly change over time. Significantly more women reported high use (>1 g daily) over time compared to low use (<0.5 g daily) (RRR = 1.21, p < 0.01). Buprenorphine use increased compared to methadone use (RRR = 1.54, p < 0.001). Rate of full-term delivery increased (RRR = 1.14, p < 0.001).

Conclusions

Severity of opioid use disorder during pregnancy did not change over time. An increase in term births and preference for buprenorphine were observed.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Total number of patients and severity metrics over time.
Fig. 2: Secondary outcomes over time.

Similar content being viewed by others

References

  1. Dart RC, Surratt HL, Cicero TJ, Parrino MW, Severtson SG, Bucher-Bartelson B, et al. Trends in opioid analgesic abuse and mortality in the United States. N. Engl J Med. 2015;372:241–8.

    Article  Google Scholar 

  2. Hedegaard H, Drug overdose deaths in the United States, 1999–2017. National Center For Health Statistics. 2018. https://www.cdc.gov/nchs/products/databriefs/db329.htm.

  3. Haight SC, Opioid Use Disorder Documented at Delivery Hospitalization—United States, 1999–2014. MMWR Morb Mortal Wkly. Rep. 2018;67:845–9.

  4. Opioid use and opioid use disorder in pregnancy. American College of Obstetricians and Gynecologists. (2017). https://www.acog.org/clinical/clinical-guidance/committee-opinion/articles/2017/08/opioid-use-and-opioid-use-disorder-in-pregnancy

  5. Stam NC, Gerostamoulos D, Gerstner-Stevens J, Scott N, Smith K, Drummer OH, et al. Determining the effective dose of street-level heroin: a new way to consider fluctuations in heroin purity, mass and potential contribution to overdose. Forensic Sci Int. 2018;290:219–26.

    Article  CAS  Google Scholar 

  6. Gilson TP, Heroin/Fentanyl/Cocaine related deaths in Cuyahoga County. Cuyahoga County Medical Examiner’s Office (2020). http://medicalexaminer.cuyahogacounty.us/pdf_medicalexaminer/en-US/HeroinFentanylReports/011920-HeroinFentanylReport.pdf

  7. Pinto S, Dodd S, Walkinshaw S, Siney C, Kakkar P, Mousa H. Substance abuse during pregnancy: effect on pregnancy outcomes. EJOG. 2010;150:137–41.

    CAS  Google Scholar 

  8. Creanga AA, Sabel JC, Ko JY, Wasserman CR, Shapiro-Mendoza CK, Taylor P, et al. Maternal drug use and its effect on neonates: a population-based study in Washington State. Obstet Gynecol. 2012;119:924–33.

  9. Low birth weight and preterm birth. Ohio Department of Health. (2014). https://odh.ohio.gov/wps/wcm/connect/gov/e4fdb2fe-8ed5-4aed-a0e7-030471fff411/Low-Birth-Weight-2014.pdf?MOD=AJPERES&CONVERT_TO=url&CACHEID=ROOTWORKSPACE.Z18_M1HGGIK0N0JO00QO9DDDDM3000-e4fdb2fe-8ed5-4aed-a0e7-030471fff411-mqycGfX

  10. Johnson T, Conrey EJ, Oza-Frank R, Arendt A, Mattson B, Montgomery M, Extremely premature births in Ohio, 2017. Ohio Department of Health (2018). https://odh.ohio.gov/wps/wcm/connect/gov/0315225f-0275-49b4-9fbf-5ec98e3ac590/Extremely+Premature+Births+in+Ohio+2017-+report.pdf?MOD=AJPERES&CONVERT_TO=url&CACHEID=ROOTWORKSPACE.Z18_M1HGGIK0N0JO00QO9DDDDM3000-0315225f-0275-49b4-9fbf-5ec98e3ac590-mLmEjsu

  11. Binder T, Vavrinková B. Prospective randomised comparative study of the effect of buprenorphine, methadone and heroin on the course of pregnancy, birthweight of newborns, early postpartum adaptation and course of the neonatal abstinence syndrome in women followed up in the outpatient department. Neuro Endocrinol Lett. 2008;29:80–86.

    CAS  PubMed  Google Scholar 

  12. Zedler BK, Mann AL, Kim MM, Amick HR, Joyce AR, Murrelle EL, et al. Buprenorphine compared with methadone to treat pregnant women with opioid use disorder: a systematic review and meta-analysis of safety in the mother, fetus and child. Addiction 2016;111:2115–28.

    Article  Google Scholar 

  13. Chen CY, Wang IA, Fang SY, Huang N, Tsay JH, Chang SH. Inadequate prenatal care utilization among women with and without methadone-treated opioid use disorders in Taiwan. Int J Drug Policy. 2019;67:1–8.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Contributions

SS: Conceptualization, Methodology, Investigation, Data curation, Formal analysis, Writing–Original draft, Visualization. GBS: Conceptualization, Methodology, Investigation, Data curation, Formal analysis, Writing–Original draft, Visualization. JLB: Writing–Review & Editing, Supervision, Project administration.

Corresponding author

Correspondence to Gouri B. Sadananda.

Ethics declarations

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sundaresh, S., Sadananda, G.B. & Bailit, J.L. Trends in the severity of opioid use disorder during pregnancy over time. J Perinatol 42, 1032–1037 (2022). https://doi.org/10.1038/s41372-022-01336-2

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41372-022-01336-2

Search

Quick links